Aemetis (AMTX) Stock Price, News & Analysis

Company Overview

Aemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies USP alcohol and hand sanitizer; and produces renewable natural gas, as well as distilled biodiesel from various vegetable oil and animal waste feedstocks. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies. Aemetis, Inc. is headquartered in Cupertino, California.

Key Stats

• Today's Range: $2.58 to $2.68
• 50-Day Range: $2.04 to $3.49
• 52-Week Range: $1.22 to $4.73
• Volume: 491,941 shs
• Average Volume: 784,063 shs
• Market Capitalization: $166.95 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $17.00
• Consensus Rating: Buy

Aemetis Stock Analysis - MarketRank™

Aemetis scored higher than 33% of companies evaluated by MarketBeat, and ranked 213th out of 268 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Aemetis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Aemetis has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Aemetis are expected to grow in the coming year, from ($2.07) to ($0.70) per share.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.79% of the float of Aemetis has been sold short.

Short Interest Ratio / Days to Cover

Aemetis has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Aemetis has recently increased by 3.49%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Aemetis does not currently pay a dividend.

Dividend Growth

Aemetis does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

8.79% of the float of Aemetis has been sold short.

Short Interest Ratio / Days to Cover

Aemetis has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Aemetis has recently increased by 3.49%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Aemetis this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for AMTX on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.

MarketBeat Follows

2 people have added Aemetis to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Aemetis insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $66,924.00 in company stock.

Percentage Held by Insiders

15.90% of the stock of Aemetis is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 27.02% of the stock of Aemetis is held by institutions.

AMTX Stock Analysis - Frequently Asked Questions

How have AMTX shares performed this year?

Aemetis' stock was trading at $2.69 at the start of the year. Since then, AMTX shares have decreased by 1.9% and is now trading at $2.64.

How were Aemetis' earnings last quarter?

Aemetis, Inc (NASDAQ:AMTX) posted its quarterly earnings results on Thursday, August, 7th. The specialty chemicals company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.35) by $0.06. The specialty chemicals company had revenue of $52.24 million for the quarter, compared to analyst estimates of $78.68 million.
Read the conference call transcript.

Who are Aemetis' major shareholders?

Aemetis' top institutional investors include Grantham Mayo Van Otterloo & Co. LLC (2.63%), Geode Capital Management LLC (1.02%), Jane Street Group LLC (0.40%) and Group One Trading LLC. Insiders that own company stock include Francis P Barton, Naomi Louise Boness and John R Block.
View institutional ownership trends.

How do I buy shares of Aemetis?

Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Aemetis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aemetis investors own include Waste Connections (WCN), DiamondRock Hospitality (DRH), American Water Works (AWK), The RMR Group (RMR), AU Optronics (AUOTY), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR).

Company Calendar

• Last Earnings: 8/07/2025
• Today: 8/26/2025
• Next Earnings (Estimated): 11/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Energy
• Industry: Biofuels
• Sub-Industry: Chemicals
• Current Symbol: NASDAQ:AMTX
• CIK: 738214
• Web: www.aemetis.com
• Phone: (408) 213-0940
• Fax: 408-252-8044
• Employees: 160
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Aemetis: $17.00
• High Price Target: $28.00
• Low Price Target: $3.00
• Potential Upside/Downside: +543.9%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.62)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$87.54 million
• Net Margins: -36.70%
• Pretax Margin: -45.38%
• Return on Equity: N/A
• Return on Assets: -33.18%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.06
• Quick Ratio: 0.02

Sales & Book Value

• Annual Sales: $267.64 million
• Price / Sales: 0.62
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($4.57) per share
• Price / Book: -0.58

Miscellaneous

• Outstanding Shares: 63,240,000
• Free Float: 53,186,000
• Market Cap: $166.95 million
• Optionable: Optionable
• Beta: 1.49